The Oncogenic Lung Cancer Fusion Kinase CD74-ROS Activates a Novel Invasiveness Pathway through E-Syt1 Phosphorylation
Cancer Research, 08/03/2012
Jun HJ et al. – The findings indicate that E–Syt1 is a mediator of cancer cell invasion and molecularly define ROS fusion kinases as therapeutic targets in the treatment of non–small cell lung cancer (NSCLC).



